Aaron VanDevender

Aaron VanDevender

Directeur/Bestuurslid bij MARKFORGED HOLDING CORPORATION

Vermogen: 202 871 $ op 30-04-2024

44 jaar
Finance
Non-Energy Minerals
Consumer Services

Oorsprong van het eerstegraads netwerk van Aaron VanDevender

EntiteitType entiteitIndustrie
Public Company Biotechnology 19
15
Holding Company Drugstore Chains 15
Public Company Industrial Machinery 13
5
Holding Company Computer Processing Hardware 5

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Aaron VanDevender via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
AMGEN INC. Pharmaceuticals: Major

John Smither

Derek Maclean

Chief Administrative Officer

Corporate Officer/Principal

Pharmaceuticals: Major

Helen Kim

Charles Olson

Corporate Officer/Principal

Corporate Officer/Principal

Investment Banks/Brokers

Graham Cooper

Shawn Cross

Corporate Officer/Principal

Analyst-Equity

REVVITY, INC. Medical Specialties

James L. Corbett

Frank R. Witney Witney

Corporate Officer/Principal

Director/Board Member

STANDARD BIOTOOLS INC. Medical Specialties

Martin Madaus

Frank R. Witney Witney

Director/Board Member

Director/Board Member

GENELUX CORPORATION Pharmaceuticals: Major

John Smither

Director/Board Member

KYTHERA BIOPHARMACEUTICALS INC Pharmaceuticals: Major

Douglas A. Rich

John Smither

Chief Operating Officer

Director of Finance/CFO

KORNIT DIGITAL LTD. Industrial Machinery

Shai Terem

Dorit Liberman

Corporate Officer/Principal

Human Resources Officer

Information Technology Services

Paul Milbury

Michael Medici

Director/Board Member

Director/Board Member

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Helen Kim

Charles Olson

Consultant / Advisor

Corporate Officer/Principal

Miscellaneous Commercial Services

Stratton Sclavos

Carol J. Meyers

Director/Board Member

Consultant / Advisor

PRINCIPIA BIOPHARMA INC. Pharmaceuticals: Major

John Smither

Director/Board Member

Miscellaneous Commercial Services

Sharon Kedar

Adam Kolom

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Andrew Hally

Antonio Rodriguez

Undergraduate Degree

Undergraduate Degree

Stanford University College/University

Fariba Danesh

Antonio Rodriguez

Daniel Levner

John Howard

Masters Business Admin

Masters Business Admin

Doctorate Degree

Corporate Officer/Principal

University of Toronto College/University

Carolyn Finkle

Tahir Mahmood

Graduate Degree

Graduate Degree

University of California, Davis College/University

Stratton Sclavos

Randall J. Mrsny

Charlene Banard

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

University of California, Santa Barbara College/University

Charles Olson

Brandon Hants

Graduate Degree

Undergraduate Degree

University of Florida College/University

Eric Moessinger

Undergraduate Degree

Telecommunications Equipment

Edward Anderson

Paul Milbury

Director/Board Member

Director of Finance/CFO

Pharmaceuticals: Major

Helen Kim

Randall J. Mrsny

Director/Board Member

Founder

Investment Managers

Eric Moessinger

Private Equity Investor

Pharmaceuticals: Major

John Smither

Director/Board Member

Columbia Law School College/University

Earl Douglas

Stephen Karp

Graduate Degree

Graduate Degree

KITE PHARMA INC Biotechnology

Helen Kim

John Smither

Private Equity Investor

Director of Finance/CFO

The University of Chicago Booth School of Business College/University

Helen Kim

Shai Terem

Graduate Degree

Masters Business Admin

Miscellaneous Commercial Services

John Smither

Director/Board Member

Biotechnology

Shlomo Melmed

Eric Moessinger

Director/Board Member

Director/Board Member

Analytical Life Science & Diagnostics Association

James L. Corbett

Martin Madaus

Director/Board Member

Director/Board Member

Harvard Business School College/University

Sharon Kedar

Alan Masarek

Masters Business Admin

Masters Business Admin

Columbia Business School College/University

Edward Anderson

Shawn Cross

Graduate Degree

Masters Business Admin

Stanford Graduate School of Business College/University

Graham Cooper

Antonio Rodriguez

Masters Business Admin

Masters Business Admin

Duke University School of Law College/University

David Lamond

Graduate Degree

ASSEMBLY BIOSCIENCES, INC. Pharmaceuticals: Major

Graham Cooper

Helen Kim

Director of Finance/CFO

Director/Board Member

Packaged Software

Edward Anderson

Andrew Hally

Director/Board Member

Sales & Marketing

Biotechnology

Martin Madaus

Sharon Kedar

Director/Board Member

Director/Board Member

LUCIRA HEALTH, INC. Medical Specialties

David Lamond

Chairman

UNITY BIOTECHNOLOGY, INC. Biotechnology

Graham Cooper

Douglas A. Rich

John Smither

Director/Board Member

Chief Operating Officer

Director of Finance/CFO

ARCUTIS BIOTHERAPEUTICS, INC. Pharmaceuticals: Major

John Smither

Director of Finance/CFO

Ubuntu Pathways

David Lamond

Director/Board Member

TELESIS BIO, INC. Miscellaneous Commercial Services

Frank R. Witney Witney

Sharon Kedar

Chairman

Director/Board Member

Pharmaceuticals: Major

David Lamond

Director/Board Member

Inquis Clinical Research Ltd.

David Lamond

Director/Board Member

Electronic Production Equipment

Carol J. Meyers

Alan Masarek

Michael Medici

Antonio Rodriguez

Shai Terem

Stephen Karp

Director/Board Member

Chairman

Director/Board Member

Director/Board Member

Chief Executive Officer

General Counsel

EFFECTOR THERAPEUTICS, INC. Biotechnology

John Smither

Elizabeth Bhatt

Director/Board Member

Director/Board Member

FRAZIER LIFESCIENCES ACQUISITION CORPORATION Pharmaceuticals: Major

John Smither

Director/Board Member

Miscellaneous Commercial Services

David Lamond

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 42
Canada 4
Israël 2
Kaaimaneilanden 2
Italië 2

Sectoraal

Health Technology 22
Consumer Services 13
Commercial Services 6
Technology Services 4
Finance 3

Operationeel

Director/Board Member 218
Corporate Officer/Principal 109
Independent Dir/Board Member 53
Undergraduate Degree 36
Chief Executive Officer 34
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU